New member | Lovaltech

7 February 2024

Lovaltech is developing protein vaccines for nasal administration, giving them 3 major benefits:

  • Stopping the transmission of viruses and therefore contagiousness,
  • active on current but also future variants,
  • and stable so they can be stored at room temperature.

In addition, Lovaltech vaccines are non-invasive, which presents an important advantage for the acceptance of vaccination, particularly among young people.

Find out more about Lovaltech: